Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Wild

Showing results (91-100 of 132) with videos related to

Pageof 14
Sort By:
Trials|July 9, 2013
The impact of supported telemetric monitoring in people with type 2 diabetes: study protocol for a randomised controlled trialSarah Wild, Janet Hanley, Stephanie Lewis, et al.
Diabetes Care|November 10, 2012
Association between BMI measured within a year after diagnosis of type 2 diabetes and mortalityJennifer Logue, Jeremy J Walker, Graham Leese, et al.
International Journal of Epidemiology|March 30, 2010
Bayesian methods for instrumental variable analysis with genetic instruments ('Mendelian randomization'): example with urate transporter SLC2A9 as an instrumental variable for effect of urate levels on metabolic syndromePaul M McKeigue, Harry Campbell, Sarah Wild, et al.
Diabetologia|September 2, 2018
Amputation-free survival in 17,353 people at high risk for foot ulceration in diabetes: a national observational studyThenmalar Vadiveloo, William Jeffcoate, Peter T Donnan, et al.
BMJ Open|June 25, 2013
Telemonitoring-based service redesign for the management of uncontrolled hypertension (HITS): cost and cost-effectiveness analysis of a randomised controlled trialAndrew Stoddart, Janet Hanley, Sarah Wild, et al.
The Lancet. Diabetes & Endocrinology|March 24, 2017
Essential medicines and access to insulinGeoff Gill, John S Yudkin, Solomon Tesfaye, et al.
BMJ (Clinical Research Ed.)|May 28, 2013
Telemonitoring based service redesign for the management of uncontrolled hypertension: multicentre randomised controlled trialBrian McKinstry, Janet Hanley, Sarah Wild, et al.
Scientific Reports|September 2, 2016
Projecting the COPD population and costs in England and Scotland: 2011 to 2030Susannah McLean, Martine Hoogendoorn, Rudolf T Hoogenveen, et al.
BMJ Open Diabetes Research & Care|March 5, 2021
What factors explain the much higher diabetes prevalence in Russia compared with Norway? Major sex differences in the contribution of adiposityOlena Iakunchykova, Maria Averina, Tom Wilsgaard, et al.
BMC Medicine|November 13, 2019
Representation of people with comorbidity and multimorbidity in clinical trials of novel drug therapies: an individual-level participant data analysisPeter Hanlon, Laurie Hannigan, Jesus Rodriguez-Perez, et al.
Pageof 14

Showing results (91-100 of 132) with videos related to

Sort By:
Pageof 14
Trials|July 9, 2013
The impact of supported telemetric monitoring in people with type 2 diabetes: study protocol for a randomised controlled trialSarah Wild, Janet Hanley, Stephanie Lewis, et al.
Diabetes Care|November 10, 2012
Association between BMI measured within a year after diagnosis of type 2 diabetes and mortalityJennifer Logue, Jeremy J Walker, Graham Leese, et al.
International Journal of Epidemiology|March 30, 2010
Bayesian methods for instrumental variable analysis with genetic instruments ('Mendelian randomization'): example with urate transporter SLC2A9 as an instrumental variable for effect of urate levels on metabolic syndromePaul M McKeigue, Harry Campbell, Sarah Wild, et al.
Diabetologia|September 2, 2018
Amputation-free survival in 17,353 people at high risk for foot ulceration in diabetes: a national observational studyThenmalar Vadiveloo, William Jeffcoate, Peter T Donnan, et al.
BMJ Open|June 25, 2013
Telemonitoring-based service redesign for the management of uncontrolled hypertension (HITS): cost and cost-effectiveness analysis of a randomised controlled trialAndrew Stoddart, Janet Hanley, Sarah Wild, et al.
The Lancet. Diabetes & Endocrinology|March 24, 2017
Essential medicines and access to insulinGeoff Gill, John S Yudkin, Solomon Tesfaye, et al.
BMJ (Clinical Research Ed.)|May 28, 2013
Telemonitoring based service redesign for the management of uncontrolled hypertension: multicentre randomised controlled trialBrian McKinstry, Janet Hanley, Sarah Wild, et al.
Scientific Reports|September 2, 2016
Projecting the COPD population and costs in England and Scotland: 2011 to 2030Susannah McLean, Martine Hoogendoorn, Rudolf T Hoogenveen, et al.
BMJ Open Diabetes Research & Care|March 5, 2021
What factors explain the much higher diabetes prevalence in Russia compared with Norway? Major sex differences in the contribution of adiposityOlena Iakunchykova, Maria Averina, Tom Wilsgaard, et al.
BMC Medicine|November 13, 2019
Representation of people with comorbidity and multimorbidity in clinical trials of novel drug therapies: an individual-level participant data analysisPeter Hanlon, Laurie Hannigan, Jesus Rodriguez-Perez, et al.
Pageof 14